Literature DB >> 24462807

Differentiation of Cronobacter spp. by tryptic digestion of the cell suspension followed by MALDI-TOF MS analysis.

Lukáš Krásný1, Eva Rohlová2, Helena Růžičková2, Jiří Santrůček2, Radovan Hynek2, Igor Hochel2.   

Abstract

Intact cell MALDI-TOF mass spectrometry is a rapid tool for the identification and classification of microorganisms, now widely used even in clinical laboratories. However, its distinctive power is not sufficient for some closely-related species. The genus Cronobacter, formerly known as Enterobacter sakazakii, contains such species. In this work, a new method for the differentiation of five Cronobacter species is presented involving the tryptic digestion of cytoplasmatic proteins followed by MALDI mass spectrometry analysis. A database was developed for use in Bruker Biotyper software including 52 reference spectra and tested on a set of 45 samples with an overall accuracy of about 80%. The possibility of measurement automation and the short time and low cost requirements of this method compared to those of biochemical tests or PCR methods make it a supplementary option to intact cell MALDI, providing additional information about the differentiation of problematic species.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biotyper; Cronobacter; MALDI-TOF; Mass spectrometry; Trypsin

Mesh:

Year:  2014        PMID: 24462807     DOI: 10.1016/j.mimet.2014.01.008

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  2 in total

1.  Cronobacter Species in Powdered Infant Formula and Their Detection Methods.

Authors:  Xinjie Song; Hui Teng; Lei Chen; Myunghee Kim
Journal:  Korean J Food Sci Anim Resour       Date:  2018-04-30       Impact factor: 2.622

2.  Identification of Pathogenic Bacteria from Public Libraries via Proteomics Analysis.

Authors:  Ryan Hyunjae Jung; Minzae Kim; Bhoomi Bhatt; Jong Min Choi; Jung H Roh
Journal:  Int J Environ Res Public Health       Date:  2019-03-14       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.